Waste Categories Sample Clauses

Waste Categories. 9.1 The separate waste streams the Contractor(s) will be required to manage under this framework are specified in sections 25.1 to 25.6 of this specification. This list is not exhaustive and may be subject to change throughout the life of the contract. 9.2 Contractor(s) at Mini Competition stage will be requested to disclose subcontractors/third parties that may be utilised to provide the service to the Participating Authority.
View SourceView Similar (2)
Waste Categories. The separate waste streams the Contractor(s) will be required to manage under this framework are specified in sections 25.1 to 25.6 of this specification. This list is not exhaustive and may be subject to change throughout the life of the contract. Contractor(s) at Mini Competition stage will be requested to disclose subcontractors/third parties that may be utilised to provide the service to the Participating Authority. The service schedule requirements for the Participating Authority(s) will be provided within the Mini Competition document for each individual Participating Authority(s). The Participating Authority(s) encourages Contractors to provide any suggestions to improve the service schedules or the use of alternative waste holding/storage equipment. Proposals should be outlined in writing within the Mini Competition tender proposal and any associated costs should be included in the Mini Competition Offer Schedule. Variations in service requirements will be notified to the Contractor(s) as and when required. The period of notice for variations will be subject to individual participating Participating Authority/Participating Authority service criteria. A mechanism for agreeing variations will be agreed between the Participating Authority(s) and the Contractor(s) prior to the contract award. Contractors are required to provide a proposed mechanism for agreeing variations as part of their submission for NHS SBS consideration. Please note that the locations/collections frequencies and other details may be subject to change during the contract term. The Participating Authority(s) reserve the right to add or delete sites as appropriate.
View Source
Waste Categories. For the purposes of this contract, a number of separate waste streams have been identified that the Bidder will be required to manage under this contract. However, this list is not exhaustive and will be subject to change throughout the contract period. Any changes and potential cost impacts are to be negotiated between the contractor and the Trusts. The Bidder is required to provide pricing for the separate groups of waste which are listed below : (and as detailed in Documents 2 2.1 and 2.2):- Isotopes Clinical Waste General Municipal Waste Recyclables Mercury Scrap Metal Glass Waste Kitchen Oil Lab Chemicals Estates Chemicals Paint IT Equipment Fridges Fluorescent tubes Furniture Mattresses Toner Carts Shredding (IT Data) Cytotoxics Drugs Food Cardboard Aerosols Batteries Body Parts & Foetal Tissue X-ray Films 6 Specification Requirements 6.1 Bedford Hospital NHS Trust, Luton and Dunstable University Hospital and ▇▇▇▇▇▇ Keynes University NHS Foundation Trust As each Trust functions independently, the individual requirements of each Trust are detailed in he following section. 6.2 The Bidder is required to provide a Total Waste Management service to the locations and at the requencies specified in Documents 2 (Luton & Dunstable Hospital NHS Trust), Document 2.1 (Bedford Hospital NHS Trust) and Document 2.2 (▇▇▇▇▇▇ Keynes University NHS Foundation Trust) 6.3 The Trusts requires the Bidder to provide new compliant waste containers, including containers or recyclables, as defined by legislation or to be agreed with the Trusts. 6.4 Segregated waste will be delivered by Trust staff to central locations ready for collection. Not used
View Source
Waste Categories. 4.1 This Lot covers the provision of a safe, sustainable and compliant managed solution for the management of medical sharps waste utilising reusable sharps containers. This will include the implementation, supply, collection, cleaning and return of such containers. 4.2 The definition of Medical Sharps Waste is set out in the Health Technical Memorandum HTM 07-01. 4.3 Waste under this Lot may include (but is not limited to): • Needles • Hypodermic needles • Scalpels and other blades • Trocars • Infusion sets • Saws • Broken glass • Sharps contaminated with cytotoxic and cytostatic medicinal products • Medicines including DOOP bins (Disposal Of Old Pharmaceuticals) 4.4 In addition to items contaminated with medical / bio hazardous waste such as broken glassware, glassware with sharp edges or points, Pasteur pipettes, glass slides etc. and other wastes that are generated as part of the Sharps Service i.e. plaster casts, single use dental equipment, medicinally contaminated items and single use surgical instruments, whether recyclable or non-recyclable etc.
View Source
Waste Categories. The waste categories were developed based on waste type, treatment technologies, and regulatory requirements and are described below.
View Source
Waste Categories. Where appropriate, waste must be segregated from other waste streams and subject to separate containment and labelling.
View Source

Related to Waste Categories

  • Prescription Drug Quantity Limits We limit the quantity of certain prescription drugs that you can get at one time for safety, cost-effectiveness and medical appropriateness reasons. Our clinical criteria for quantity limits are subject to our periodic review and modification. Quantity limits may restrict: • the amount of pills dispensed per thirty (30) day period; • the number of prescriptions ordered in a specified time period; or • the number of prescriptions ordered by a provider, or multiple providers. Our formulary indicates which prescription drugs have a quantity limit. Prescription drugs and diabetic equipment or supplies can be bought from the following types of pharmacies: • Retail pharmacies. These dispense prescription drugs and diabetic equipment or supplies. • Mail order pharmacies. These dispense maintenance and non-maintenance prescription drugs and diabetic equipment or supplies. • Specialty pharmacies. These dispense specialty prescription drugs, defined as such on our formulary. For information about our network retail, mail order, and specialty pharmacies, visit our website or call our Customer Service Department.

  • Prescription Drugs and Diabetic Equipment or Supplies Biological products for allergen immunotherapy and vaccinations. • Blood fractions. • Compound prescription drugs that are not made up of at least one legend drug. • Bulk powders and chemicals used in compound prescriptions that are not FDA approved, are not covered unless listed on our formulary. • Prescription drugs prescribed or dispensed outside of our dispensing guidelines. • Prescription drugs ordered or prescribed based solely on online questionnaires, telephonic interviews, surveys, emails, or any other marketing solicitation methods, whether alone or in combination. • Prescription drugs that have not proven effective according to the FDA. • Prescription drugs used for cosmetic purposes. • Prescription drugs purchased from a non-designated pharmacy, if a pharmacy has been designated for you through the Pharmacy Home Assignment program. • Experimental prescription drugs including those placed on notice of opportunity hearing status by the Federal Drug Efficacy Study Implementation (DESI). • Prescription drugs provided to you that are not dispensed by a network pharmacy or covered under your medical plan. • Prescription drugs and diabetic equipment and supplies purchased at a non-network pharmacy unless indicated as covered in the Summary of Pharmacy Benefits. • Prescription drug related medical supplies except for diabetic, regardless of the reason prescribed, the intended use, or medical necessity. Examples include, but are not limited to, alcohol pads, bandages, wraps or pill holders. • Off-label use of prescription drugs except as described in Experimental or Investigational Services in Section 3; • Prescribed weight-loss drugs. • Replacement of prescription drugs resulting from a lost, stolen, broken or destroyed prescription order or refill. • Therapeutic devices and appliances, including hypodermic needles and syringes except when used to administer insulin. • Prescription drugs, therapeutic equivalents, or any other pharmaceuticals used to treat sexual dysfunctions. • Vitamins, unless specifically listed as a covered healthcare service. • A prescription drug refill greater than the refill number authorized by your physician, more than a year from the date of the original prescription, or limited by law. • Long acting opioids and other controlled substances, nicotine replacement therapy, and specialty prescription drugs when purchased from a mail order pharmacy. • Prescription drugs and specialty prescription drugs when the required prescription drug preauthorization is not obtained. • Certain prescription drugs that have an over-the-counter (OTC) equivalent. • Prescriptions filled through an internet pharmacy that is not a verified internet pharmacy practice site certified by the National Association of Boards of Pharmacy. • Illegal drugs, including medical marijuana, which are dispensed in violation of state and/or federal law. • Services of a nurse's aide. • Services of a private duty nurse: o when the primary duties are limited to bathing, feeding, exercising, homemaking, giving oral medications or acting as companion or sitter; o after the caregiver or patient have demonstrated the ability to carry out the plan of care; o provided outside the home. Examples include at school, or in a nursing or assisted living facility; o that are duplication or overlap of services. Examples include when a person is receiving hospice care services or for the same hours of a skilled nursing home care visit; o that are for observation only; and o provided as part-time/intermittent and not continuous care. • Maintenance care when the condition has stabilized including routine ostomy care or tube feeding administration or if the anticipated need is indefinite. • Twenty-four (24) hour private duty nursing care for a person without an available caregiver in the home. • Respite care (e.g., care during a caregiver vacation) or private duty nursing so that the caregiver may attend work or school. • Abdominoplasty. • Brow ptosis surgery. • Cervicoplasty. • Chemical exfoliations, peels, abrasions, dermabrasions, or planing for acne, scarring, wrinkling, sun damage or other benign conditions. • Correction of variations in normal anatomy including augmentation mammoplasty, mastopexy, and correction of congenital breast asymmetry. • Dermabrasion. • Ear piercing or repair of a torn earlobe. • Excision of excess skin or subcutaneous tissue except for panniculectomy. • Genioplasty. • Hair transplants. • Hair removal including electrolysis epilation, unless in relation to gender reassignment services or skin grafting. • Inverted nipple surgery. • Laser treatment for acne and acne scars. • Osteoplasty - facial bone reduction. • Otoplasty. • Procedures to correct visual acuity including but not limited to cornea surgery or lens implants. • Removal of asymptomatic benign skin lesions. • Repeated cauterizations or electrofulguration methods used to remove growths on the skin. • Rhinoplasty.

  • Product Quality Isoprene, (hereinafter referred to as “Product”) supplied and maintained on consignment at Belpre in accordance with Article 6, and will be in accordance with specifications set forth in Exhibit A. Seller will facsimile to the Buyer at time of shipment a Certificate of Analysis (COA). Seller will provide Buyer six (6) months advanced notification if there is a change in the manufacturing process that will affect the material specifications of Product provided to the Buyer. Product produced by the Seller in different plants is viewed as coming from different supply sources and requires separate qualifications. Product to be shipped for the Seller from third parties must be from a third party qualified by the Buyer based on Buyer’s criteria as specified in Exhibit B. Buyer will have the right to confirm each such shipment-conforms to the agreed specification; Seller must obtain approval prior to shipment any material that does not meet the Buyers specifications. If Seller deliveries Product failing to comply with the specifications set out in Exhibit A, Seller will reimburse Buyer for freight expenses associated with such shipment and be entitled at its option to i) require Seller to replace such defective Product at a price not to exceed the invoice value or ii) to reimburse the invoice value of the defective Product. If, Buyer has cause to complain that the quality of Product delivered to it pursuant to the Contract does not comply with the specification set out in Exhibit A, Buyer will give written notice specifying the nature of its complaint and the parties will promptly meet so as to resolve that complaint. In absence of any agreement to resolve the complaint the parties will appoint at their joint cost a mutually acceptable independent surveyor to examine whether the quality of Product as delivered complied with the specifications set forth in Exhibit A. In the absence of any written notice from Buyer to Seller within 30 days after delivery of the Product, the Product shall be deemed to have been delivered and accepted by Buyer in a satisfactory condition and in all respects in accordance with the specifications and Seller shall have no liability to Buyer with respect to that delivery.

  • Power Factor Design Criteria (Reactive Power A wind generating plant shall maintain a power factor within the range of 0.95 leading to 0.95 lagging, measured at the Point of Interconnection as defined in this LGIA, if the ISO’s System Reliability Impact Study shows that such a requirement is necessary to ensure safety or reliability. The power factor range standards can be met using, for example without limitation, power electronics designed to supply this level of reactive capability (taking into account any limitations due to voltage level, real power output, etc.) or fixed and switched capacitors if agreed to by the Connecting Transmission Owner for the Transmission District to which the wind generating plant will be interconnected, or a combination of the two. The Developer shall not disable power factor equipment while the wind plant is in operation. Wind plants shall also be able to provide sufficient dynamic voltage support in lieu of the power system stabilizer and automatic voltage regulation at the generator excitation system if the System Reliability Impact Study shows this to be required for system safety or reliability.

  • Quality Assurance/Quality Control Contractor shall establish and maintain a quality assurance/quality control program which shall include procedures for continuous control of all construction and comprehensive inspection and testing of all items of Work, including any Work performed by Subcontractors, so as to ensure complete conformance to the Contract with respect to materials, workmanship, construction, finish, functional performance, and identification. The program established by Contractor shall comply with any quality assurance/quality control requirements incorporated in the Contract.